These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 8993765)
1. The influence of age on transfer factor treatment of cellular immunodeficiency, chronic fatigue syndrome and/or chronic viral infections. Hana I; Vrubel J; Pekarek J; Cech K Biotherapy; 1996; 9(1-3):91-5. PubMed ID: 8993765 [TBL] [Abstract][Full Text] [Related]
2. Lessons from a pilot study of transfer factor in chronic fatigue syndrome. De Vinci C; Levine PH; Pizza G; Fudenberg HH; Orens P; Pearson G; Viza D Biotherapy; 1996; 9(1-3):87-90. PubMed ID: 8993764 [TBL] [Abstract][Full Text] [Related]
3. Transfer factor with anti-EBV activity as an adjuvant therapy for nasopharyngeal carcinoma: a pilot study. Prasad U; bin Jalaludin MA; Rajadurai P; Pizza G; De Vinci C; Viza D; Levine PH Biotherapy; 1996; 9(1-3):109-15. PubMed ID: 8993768 [TBL] [Abstract][Full Text] [Related]
4. Treatment of childhood combined Epstein-Barr virus/cytomegalovirus infection with oral bovine transfer factor. Jones JF; Minnich LL; Jeter WS; Pritchett RF; Fulginiti VA; Wedgwood RJ Lancet; 1981 Jul; 2(8238):122-4. PubMed ID: 6113484 [TBL] [Abstract][Full Text] [Related]
5. Use of anti HHV-6 transfer factor for the treatment of two patients with chronic fatigue syndrome (CFS). Two case reports. Ablashi DV; Levine PH; De Vinci C; Whitman JE; Pizza G; Viza D Biotherapy; 1996; 9(1-3):81-6. PubMed ID: 8993763 [TBL] [Abstract][Full Text] [Related]
6. [The effect of cytomegalovirus and Epstein-Barr virus infection on immunologic signs]. Korcáková L; Vrubel J; Kaslík J; Nozicková M Vnitr Lek; 1989 Oct; 35(10):987-91. PubMed ID: 2559543 [TBL] [Abstract][Full Text] [Related]
8. Herpesviruses in the Activated Phosphatidylinositol-3-Kinase-δ Syndrome. Cohen JI Front Immunol; 2018; 9():237. PubMed ID: 29599765 [TBL] [Abstract][Full Text] [Related]
9. Herpesvirus infections in hematopoietic stem cell transplant recipients seropositive for human cytomegalovirus before transplantation. Fan J; Jing M; Yang M; Xu L; Liang H; Huang Y; Yang R; Gui G; Wang H; Gong S; Wang J; Zhang X; Zhao H; Gao H; Dong H; Ma W; Hu J Int J Infect Dis; 2016 May; 46():89-93. PubMed ID: 27057748 [TBL] [Abstract][Full Text] [Related]
10. The use of transfer factors in chronic fatigue syndrome: prospects and problems. Levine PH Biotherapy; 1996; 9(1-3):77-9. PubMed ID: 8993762 [TBL] [Abstract][Full Text] [Related]
11. Significance of viral coinfections by HIV, HTLV-I, Epstein-Barr virus, and cytomegalovirus for immunological abnormalities in hemophiliacs. Okubo S; Yasunaga K Cancer Detect Prev; 1990; 14(3):343-6. PubMed ID: 2167171 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of suitable target antigens and immunoassays for high-accuracy immune monitoring of cytomegalovirus and Epstein-Barr virus-specific T cells as targets of interest in immunotherapeutic approaches. Tischer S; Dieks D; Sukdolak C; Bunse C; Figueiredo C; Immenschuh S; Borchers S; Stripecke R; Maecker-Kolhoff B; Blasczyk R; Eiz-Vesper B J Immunol Methods; 2014 Jun; 408():101-13. PubMed ID: 24877879 [TBL] [Abstract][Full Text] [Related]
13. Serologic and immunologic responses in chronic fatigue syndrome with emphasis on the Epstein-Barr virus. Jones JF Rev Infect Dis; 1991; 13 Suppl 1():S26-31. PubMed ID: 1850541 [TBL] [Abstract][Full Text] [Related]
14. Cytomegalovirus, Epstein-Barr virus and human herpesvirus 8 salivary shedding in HIV positive men who have sex with men with controlled and uncontrolled plasma HIV viremia: a 24-month longitudinal study. Basso M; Andreis S; Scaggiante R; Franchin E; Zago D; Biasolo MA; Del Vecchio C; Mengoli C; Sarmati L; Andreoni M; Palù G; Parisi SG BMC Infect Dis; 2018 Dec; 18(1):683. PubMed ID: 30567494 [TBL] [Abstract][Full Text] [Related]
15. [Secondary post-traumatic immunodeficiency syndrome in patients in the anesthesiology-resuscitation department. Possibilities of immunomodulation therapy]. Průcha M; Limberk B Cesk Epidemiol Mikrobiol Imunol; 1992 Sep; 42(3):116-20. PubMed ID: 1339602 [TBL] [Abstract][Full Text] [Related]
16. [Epstein-Barr virus infection and lymphoproliferative disorders in patients after renal transplantation]. Merlino C; Giacchino F; Tognarelli G; Cavallo R; Re D; Sinesi F; Segoloni G; Negro Ponzi A Minerva Urol Nefrol; 1996 Sep; 48(3):139-43. PubMed ID: 8966650 [TBL] [Abstract][Full Text] [Related]
17. Serological and virological investigation of the role of the herpesviruses EBV, CMV and HHV-6 in post-infective fatigue syndrome. Cameron B; Flamand L; Juwana H; Middeldorp J; Naing Z; Rawlinson W; Ablashi D; Lloyd A J Med Virol; 2010 Oct; 82(10):1684-8. PubMed ID: 20827765 [TBL] [Abstract][Full Text] [Related]
18. IgG antibodies to human herpesvirus-6 in children and adults and in primary Epstein-Barr virus infections and cytomegalovirus infections [corrected]. Linde A; Dahl H; Wahren B; Fridell E; Salahuddin Z; Biberfeld P J Virol Methods; 1988 Sep; 21(1-4):117-23. PubMed ID: 2846607 [TBL] [Abstract][Full Text] [Related]
19. Herpesvirus infections in the acquired immune deficiency syndrome. Quinnan GV; Masur H; Rook AH; Armstrong G; Frederick WR; Epstein J; Manischewitz JF; Macher AM; Jackson L; Ames J JAMA; 1984 Jul; 252(1):72-7. PubMed ID: 6328055 [TBL] [Abstract][Full Text] [Related]
20. Impact of Aging, Cytomegalovirus Infection, and Long-Term Treatment for Human Immunodeficiency Virus on CD8 Veel E; Westera L; van Gent R; Bont L; Otto S; Ruijsink B; Rabouw HH; Mudrikova T; Wensing A; Hoepelman AIM; Borghans JAM; Tesselaar K Front Immunol; 2018; 9():572. PubMed ID: 29619031 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]